Comparison between Exhicon Events Media IPO and Infinium Pharmachem IPO.
Exhicon Events Media IPO is a SME Fixed Price IPO proposed to list at BSE SME while Infinium Pharmachem IPO is a SME Fixed Price proposed to list at NSE SME.
| Exhicon Events Media IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Share India Capital Services Pvt.Ltd. | Swastika Investmart Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Share India Securities Ltd. | Swastika Investmart Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Exhicon Events Media IPO is up to ₹19.01 Cr whereas the issue size of the Infinium Pharmachem IPO is up to ₹23.99 Cr. The final issue price of Exhicon Events Media IPO is ₹64.00 per share and of Infinium Pharmachem IPO is ₹135.00 per share.
| Exhicon Events Media IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹61.00 per share | |
| Issue Price (Upper) | ₹64.00 per share | |
| Issue Price (Final) | ₹64.00 per share | ₹135.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹13.50 per share | |
| Market Lot Size | 2000 shares | 1000 shares |
| Fresh Issue Size | 29,70,000 shares | 17,81,000 shares |
| Fresh Issue Size (Amount) | up to ₹19.01 Cr | up to ₹23.99 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 29,70,000 shares | 17,81,000 shares |
| Issue Size Total (Amount) | up to ₹19.01 Cr | up to ₹23.99 Cr |
Exhicon Events Media IPO opens on Mar 31, 2023, while Infinium Pharmachem IPO opens on Mar 31, 2023. The closing date of Exhicon Events Media IPO and Infinium Pharmachem IPO is Apr 05, 2023, and Apr 05, 2023, respectively.
| Exhicon Events Media IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 31, 2023 | Mar 31, 2023 |
| Issue Close | Apr 05, 2023 | Apr 05, 2023 |
| Basis Of Allotment (Tentative) | Apr 11, 2023 | Apr 11, 2023 |
| Initiation of Refunds (Tentative) | Apr 12, 2023 | Apr 12, 2023 |
| Credit of Share (Tentative) | Apr 13, 2023 | Apr 13, 2023 |
| Listing date (Tentative) | Apr 17, 2023 | Apr 17, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Exhicon Events Media IPO P/E ratio is 8.08, as compared to Infinium Pharmachem IPO P/E ratio of 7.83.
| Exhicon Events Media IPO | Infinium Pharmachem IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 86.20 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 62.25 | 73.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 8.08 | 7.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹76.00 Cr. | ₹93.93 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 174.23 | 43.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 123.26 | 72 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4283.80 | ₹54.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 93.11 | 46.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Exhicon Events Media IPO Retail Individual Investors (RII) are offered 10,40,000 shares while in Infinium Pharmachem IPO retail investors are offered 10,40,000 shares. Qualified Institutional Buyers (QIB) are offered 14,84,000 shares in Exhicon Events Media IPO and in Infinium Pharmachem IPO.
| Exhicon Events Media IPO | Infinium Pharmachem IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 3,30,000 shares | 94,000 shares |
| QIB | 14,84,000 shares | |
| NII | 4,46,000 shares | 8,70,000 shares |
| RII | 10,40,000 shares | 8,70,000 shares |
| Employee | 41,000 shares | |
| Others | ||
| Total | 29,70,000 shares | 17,81,000 shares |
Exhicon Events Media IPO subscribed 1.95x in total, whereas Infinium Pharmachem IPO subscribed 1.92x.
| Exhicon Events Media IPO | Infinium Pharmachem IPO | |
|---|---|---|
| QIB (times) | 1.00x | |
| NII (times) | 3.28x | 1.94x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 2.31x | 2.00x |
| Employee (times) | 1.29x | |
| Other (times) | ||
| Total (times) | 1.95x | 1.92x |
